Journal of Critical Care
Volume 24, Issue 1 , Pages 11-20 , March 2009

Neuromuscular monitoring: Old issues, new controversies

  • Aaron F. Kopman, MD

      Affiliations

    • Corresponding Author InformationTel.: +1 212 677 6706 (home), +1 212 604 2636 (office).

References 

  1. Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology. 2003;98:1037–1039
  2. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth. 2000;84:301–303
  3. Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia. 2007;62:806–809
  4. Sorgenfrei IF, Viby-Mogensen J, Swiatek FA. Does evidence lead to a change in clinical practice? Danish anaesthetists' and nurse anesthetists' clinical practice and knowledge of postoperative residual curarization. Ugeskr Laeger. 2005;167:3878–3882
  5. Fuchs-Buder T, Hofmockel R, Geldner G, et al. The use of neuromuscular monitoring in Germany. Anaesthesist. 2003;52:522–526
  6. Nava-Ocampo AA, et al. Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey BMC. Anesthesiology. 2002;2:2
  7. Christie TH, Churchill-Davidson HC. The St. Thomas's hospital nerve stimulator in the diagnosis of prolonged apnea. Lancet. 1958;1:776
  8. Cullen SC. Clinical practice with muscle relaxants. Anesthesiology. 1959;20:530–534
  9. Bendixen HH, Surtees AD, Oyama T, et al. Post-op disturbances in ventilation following the use of muscles relaxants in anesthesia. Anesthesiology. 1959;20:121–122
  10. Sahn S, Lakshminarayan S. Bedside criteria for discontinuation of mechanical ventilation. Chest. 1973;63:1002–1007
  11. Varney RF, Linegar CR, Holaday HA. The assay of curare by the rabbit “head drop” method. J Pharmacol Exp Ther. 1949;97:72–83
  12. Dam WH, Guldmann N. Inadequate post anesthetic ventilation. Anesthesiology. 1961;22:699–707
  13. Johansen SH, Jorgensen M, Molbech S. Effect of tubocurarine on respiratory and nonrespiratory muscle power in man. J Appl Physiol. 1964;19:990–994
  14. Pavlin EG, Holle RH, Schoene RB. Recovery of airway protection compared with ventilation in humans after paralysis with curare. Anesthesiology. 1989;70:381–385
  15. Walts LF, Levin N, Dillon JB. Assessment of recovery from curare. JAMA. 1970;213:1894–1896
  16. Hutton P, Burchett KR, Madden AP. Comparison of recovery after neuromuscular blockade by atracurium or pancuronium. Br J Anaesth. 1988;60:36–42
  17. Cohen AD. A simple inexpensive nerve stimulator. Anaesthesia. 1963;18:534
  18. Katz RL. A nerve stimulator for the continuous monitoring of muscle relaxant action. Anesthesiology. 1965;26:832–833
  19. Gissen AJ, Katz RL. Twitch, tetanus, and post tetanic potentiation as indices of neuromuscular block in man. Anesthesiology. 1969;30:481–487
  20. Ali HH, Utting JE, Gray TC. Stimulus frequency in the detection of neuromuscular block in man. Br J Anaesth. 1970;42:967–978
  21. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block (part 1). Br J Anaesth. 1971;43:473–477
  22. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block (part II). Br J Anaesth. 1971;43:478–485
  23. Ali HH, Wilson RS, Savarese JJ, et al. The effect of d-tubocurarine on indirectly elicited train-of-four muscle response and respiratory measurements in humans. Br J Anaesth. 1975;47:570–574
  24. Brand JB, Cullen DJ, Wilson NE, et al. Spontaneous recovery from nondepolarizing neuromuscular blockade: correlation between clinical and evoked responses. Anesth Analg. 1977;56:55–58
  25. Kopman AF, Yee PS, Neuman GG. Correlation of the train-of-four fade ratio with clinical signs and symptoms of residual curarization in awake volunteers. Anesthesiology. 1997;86:765–771
  26. Russell WJ, Searle DG. Hand grip force as an assessment of recovery from neuromuscular block. J Clin Monit. 1987;3:87–89
  27. Eriksson L. Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants. Acta Anaesthesiol Scand. 1996;40:520–523
  28. Sundman E, Witt H, Olsson R, et al. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Anesthesiology. 2000;92:977–984
  29. Beemer GH, Rozental P. Postoperative neuromuscular function. Anaesth Intens Care. 1986;14:41–45
  30. Dupuis JY, Martin R, Tétrault JP. Clinical, electrical and mechanical correlations during recovery from neuromuscular blockade with vecuronium. Can J Anaesth. 1990;37:192–196
  31. Sharpe MD, Lam AM, Nicholas FJ, et al. Correlation between integrated evoked EMG and respiratory function following atracurium administration in unanaesthetized humans. Can J Anaesth. 1990;37:307–312
  32. El Mikatti N, Wilson A, Pollard BJ, et al. Pulmonary function and head lift during spontaneous recovery from pipecuronium neuromuscular block. Br J Anaesth. 1995;74:16–19
  33. Engbæk J, Østergaard D, Viby-Mogensen J, et al. Clinical recovery and train-of-four measured mechanically and electromyographically following atracurium. Anesthesiology. 1989;71:391–395
  34. Viby-Mogensen J, Jorgensen BC, Ørding H. Residual curarization in the recovery room. Anesthesiology. 1979;50:539–541
  35. Andersen BN, Madsen JV, Schurizek BA, et al. Residual curarization: a comparative study of atracurium and pancuronium. Acta Anaesthesiol Scand. 1988;32:79–81
  36. Bevan DR, Smith CE, Donati F. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium, and pancuronium. Anesthesiology. 1988;69:272–276
  37. Debaene B, et al. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology. 2003;98:1042–1048
  38. McCaul C, Tobin E, Boylan JF, et al. Atracurium is associated with postoperative residual curarization. Br J Anaesth. 2002;89:766–769
  39. Baillard C, et al. Residual curarization in the recovery room after vecuronium. Br J Anaesth. 2000;84:394–395
  40. Hayes AH, et al. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia. 2001;56:312–318
  41. Kim KS, Lew SH, Cho HY, et al. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. Anesth Analg. 2002;95:1656–1660
  42. Viby-Mogensen J, Jensen NH, Engbaek J, et al. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology. 1985;63:440–443
  43. Miller RD. How should residual neuromuscular blockade be detected?. Anesthesiology. 1989;70:379–380
  44. Shorten GD. Postoperative residual curarisation: incidence, aetiology and associated morbidity. Anaesth Intensive Care. 1993;21:782–789
  45. Arbous MS, Meursing A, van Kleef JW, et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology. 2005;102:257–268
  46. Berg H, Viby-Mogensen J, Roed J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997;41:1095–1103
  47. Pedersen T, Viby-Mogensen J, Ringsted C. Anesthetic practice and postoperative pulmonary complications. Acta Anaesthiol Scand. 1992;36:812–818
  48. Moller JT, Wittrup M, Johansen SH. Hypoxemia in the postanesthesia care unit: an observer study. Anesthesiology. 1990;73:890–895
  49. Murphy GS, Szokol JW, Franklin M, et al. Postanesthesia care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium. Anesth Analg. 2004;98:193–200
  50. Fisher DM. Surrogate end points: are they meaningful?. Anesthesiology. 1994;81:795–796
  51. Kopman AF. Surrogate endpoints and neuromuscular recovery. Anesthesiology. 1997;87:1029–1031
  52. Isono S, Ide T, Kochi T, et al. Effects of partial paralysis on the swallowing reflex in conscious humans. Anesthesiology. 1991;75:980–984
  53. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth. 2007;98:302–316
  54. Pedersen T, Viby-Mogensen J, Bang U, et al. Does perioperative tactile evaluation of the train-of-four response influence the frequency of postoperative residual neuromuscular blockade?. Anesthesiology. 1990;73:835–839
  55. Fawcett WJ, Dash A, Francis GA, et al. Recovery from neuromuscular blockade: residual curarisation following atracurium or vecuronium by bolus dosing or infusions. Acta Anaesthiol Scand. 1995;39:288–293
  56. Kopman AF, Kopman DJ, Ng J, et al. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function. J Clin Anesth. 2005;17:30–35
  57. Kopman AF, Zank LM, Ng J, et al. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory?. Anesth Analg. 2004;98:102–106
  58. Beemer GH, Goonetilleke PH, Bjorksten AR. The maximum depth of an atracurium neuromuscular block antagonized by edrophonium to effect adequate recovery. Anesthesiology. 1995;82:852–858
  59. Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology. 2002;96:45–50
  60. Mackintosh RR. Death following injection of neostigmine. Br Med J. 1949;1:852
  61. Pooler HE. Atropine, neostigmine, and sudden deaths. Anaesthesia. 1957;12:198–202
  62. Lovstad RZ, Thagaard KS, Berner NS, et al. Neostigmine 50 microg kg(-1) with glycopyrrolate increases postoperative nausea in women after laparoscopic gynaecological surgery. Acta Anaesthesiol Scand. 2001;45:495–500
  63. Cheng C, Sessler DI, Apfel CC. Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting?. Anesth Analg. 2005;101:1349–1355
  64. Payne JP, Hughes R, Al Azawi S. Neuromuscular blockade by neostigmine in anesthetized man. Br J Anaesth. 1981;52:69–76
  65. Caldwell JE. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesth Analg. 1995;80:1168–1174
  66. Kopman AF, Sinha N. Acceleromyography as a guide to anesthetic management. A case report. J Clin Anesth. 2003;15:145–148
  67. Gatke MR, Viby-Mogensen J, Rosenstock C, et al. Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand. 2002;46:207–213
  68. Mortensen CR, Berg H, El-Mahdy A, Viby-Mogensen J. Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium. Acta Anaesthiol Scand. 1995;39:797–801
  69. Baillard C, Clec'h C, Catineau J, et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth. 2005;95:622–626
  70. Claudius C, Karacan H, Viby-Mogensen J. Prolonged residual paralysis after a single intubating dose of rocuronium. BJA Bol Jurisprud. 2007;99:514–517
  71. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002;41:266–270
  72. Epemolu O, Bom A, Hope F, et al. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent org 25969. Anesthesiology. 2003;99:632–637
  73. Belmont MR, Horochiwsky Z, Eliazo RF, et al. Reversal of AV430A with cysteine in rhesus monkeys. Anesthesiology. 2004;[ASA Abstract # A1180]
  74. de Boer H, Driessen JJ, Marcus MAE, et al. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology. 2007;107:239–244
  75. Shields M, Giovannelli M, Mirakhur RK, et al. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth. 2006;96:36–43

PII: S0883-9441(08)00064-6

doi: 10.1016/j.jcrc.2008.02.008

Journal of Critical Care
Volume 24, Issue 1 , Pages 11-20 , March 2009

Article Tools

* Image Usage & Resolution